期刊论文详细信息
Cardiovascular Diabetology
Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies
Original Investigation
Ute Ellert1  Hannelore Neuhauser1  Sabine Schipf2  Henry Völzke2  Teresa Tamayo3  Wolfgang Rathmann3  Ina-Maria Rückert4  Christa Meisinger5  Klaus Berger6  Grit Müller6  Rolf Holle7  Michaela Schunk7  Alexander Kluttig8  Karin-Halina Greiser9  Susanne Moebus1,10  Silke Andrich1,10 
[1] Department of Epidemiology and Health Reporting, Robert-Koch-Institute, Berlin, Germany;Institute for Community Medicine, Ernst Moritz Arndt-University, Greifswald, Germany;Institute of Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes, Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany;Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Ingolstädter Landstrasse 1, D-85764, München/Neuherberg, Germany;Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Ingolstädter Landstrasse 1, D-85764, München/Neuherberg, Germany;MONICA/KORA Myocardial Infarction Registry, Central Hospital of Augsburg, Augsburg, Germany;Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany;Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany;Institute of Medical Epidemiology, Biostatistics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany;Institute of Medical Epidemiology, Biostatistics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany;Division of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany;Institute of Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany;
关键词: Type 2 Diabetes;    Hypertension;    Dyslipidemia;    Adherence to guidelines;    Pharmacological treatment;   
DOI  :  10.1186/1475-2840-11-50
 received in 2012-03-05, accepted in 2012-04-05,  发布年份 2012
来源: Springer
PDF
【 摘 要 】

BackgroundAlthough most deaths among patients with type 2 diabetes (T2D) are attributable to cardiovascular disease, modifiable cardiovascular risk factors appear to be inadequately treated in medical practice. The aim of this study was to describe hypertension, dyslipidemia and medical treatment of these conditions in a large population-based sample.MethodsThe present analysis was based on the DIAB-CORE project, in which data from five regional population-based studies and one nationwide German study were pooled. All studies were conducted between 1997 and 2006. We assessed the frequencies of risk factors and co-morbidities, especially hypertension and dyslipidemia, in participants with and without T2D. The odds of no or insufficient treatment and the odds of pharmacotherapy were computed using multivariable logistic regression models. Types of medication regimens were described.ResultsThe pooled data set comprised individual data of 15, 071 participants aged 45–74 years, including 1287 (8.5%) participants with T2D. Subjects with T2D were significantly more likely to have untreated or insufficiently treated hypertension, i.e. blood pressure of > = 140/90 mmHg (OR = 1.43, 95% CI 1.26-1.61) and dyslipidemia i.e. a total cholesterol/HDL-cholesterol ratio > = 5 (OR = 1.80, 95% CI 1.59-2.04) than participants without T2D. Untreated or insufficiently treated blood pressure was observed in 48.9% of participants without T2D and in 63.6% of participants with T2D. In this latter group, 28.0% did not receive anti-hypertensive medication and 72.0% were insufficiently treated. In non-T2D participants, 28.8% had untreated or insufficiently treated dyslipidemia. Of all participants with T2D 42.5% had currently elevated lipids, 80.3% of these were untreated and 19.7% were insufficiently treated.ConclusionsBlood pressure and lipid management fall short especially in persons with T2D across Germany. The importance of sufficient risk factor control besides blood glucose monitoring in diabetes care needs to be emphasized in order to prevent cardiovascular sequelae and premature death.

【 授权许可】

CC BY   
© Rückert et al.; licensee BioMed Central Ltd. 2012

【 预 览 】
附件列表
Files Size Format View
RO202311108621485ZK.pdf 759KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  • [50]
  • [51]
  • [52]
  • [53]
  • [54]
  文献评价指标  
  下载次数:7次 浏览次数:1次